A review of the controlled trials of pharmacotherapy and psychotherapy in the treatment of bulimia nervosa.

Abstract

The treatment literature on bulimia nervosa includes several double-blind placebo controlled studies, the majority of which examine the use of antidepressants in bulimia nervosa. The psychotherapy literature has focused heavily on the use of cognitive behavioral therapy (CBT) in the treatment of this eating disorder. Some studies have compared CBT to other types of therapy or waiting list controls. The following review will examine the methodology and outcome of the pharmacotherapy and psychotherapy treatment studies of bulimia nervosa. The authors conclude that while the studies indicate treatment is somewhat effective, there remains uncertainty regarding the long-term effectiveness of most of the reported treatments.

• Authors: J E Mitchell, N Raymond, S Specker
• Journal: The International journal of eating disorders (Int J Eat Disord) Vol. 14 Issue 3 Pg. 229-47 (Nov 1993) ISSN: 0276-3478 [Print] United States
• PMID: 8275060 (Publication Type: Comparative Study, Journal Article, Review)

Chemical References

• Antidepressive Agents
• Lithium Carbonate
• Naltrexone

Topics

• Antidepressive Agents (adverse effects, therapeutic use)
• Bulimia (psychology, therapy)
• Clinical Trials as Topic
• Cognitive Behavioral Therapy
• Dose-Response Relationship, Drug
• Double-Blind Method
• Female
• Humans
• Lithium Carbonate (adverse effects, therapeutic use)
• Naltrexone (adverse effects, therapeutic use)